These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20559966)

  • 1. Myocardial viability in chronic ischemic cardiomyopathy: similarities and discordance of different diagnostic approaches.
    Weissman G; Asch FM
    J Cardiovasc Transl Res; 2009 Mar; 2(1):24-9. PubMed ID: 20559966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.
    Briceno N; Schuster A; Lumley M; Perera D
    Heart; 2016 Mar; 102(5):397-406. PubMed ID: 26740480
    [No Abstract]   [Full Text] [Related]  

  • 3. Does imaging-guided selection of patients with ischemic heart failure for high risk revascularization improve identification of those with the highest clinical benefit?: Imaging-guided selection of patients with ischemic heart failure for high-risk revascularization improves identification of those with the highest clinical benefit.
    Mielniczuk LM; Beanlands RS
    Circ Cardiovasc Imaging; 2012 Mar; 5(2):262-70; discussion 270. PubMed ID: 22438424
    [No Abstract]   [Full Text] [Related]  

  • 4. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF; Poldermans D; Rizzello V; Vanoverschelde JL; Elhendy A; Boersma E; Roelandt JR; Bax JJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):385-90. PubMed ID: 14762345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is cardiac magnetic resonance imaging assessment of myocardial viability useful for predicting which patients with impaired ventricles might benefit from revascularization?
    Child NM; Das R
    Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):395-8. PubMed ID: 22279116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of hibernating myocardium in ischemic left ventricular dysfunction.
    Schinkel AF; Bax JJ; Delgado V; Poldermans D; Rahimtoola SH
    Am J Med; 2010 Nov; 123(11):978-86. PubMed ID: 21035587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nearly circumferential delayed contrast enhancement in severe ischemic cardiomyopathy.
    Leurent G; Donal E; Langella B
    Arch Cardiovasc Dis; 2008 Jan; 101(1):70-1. PubMed ID: 18391877
    [No Abstract]   [Full Text] [Related]  

  • 8. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction.
    Abdul Ghaffar Y; Maskoun W; Mustafa NG; Feigenbaum H; Sawada SG
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1651-1659. PubMed ID: 31053980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of dobutamine stress echocardiography in myocardial viability.
    Schinkel AF; Poldermans D; Elhendy A; Bax JJ
    Curr Opin Cardiol; 2006 Sep; 21(5):443-9. PubMed ID: 16900006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
    Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
    Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of myocardial viability: review of the clinical significance.
    Ramos M; DePasquale E; Coplan NL
    Rev Cardiovasc Med; 2008; 9(4):225-31. PubMed ID: 19122580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial viability at dobutamine echocardiography by deformation analysis using tissue velocity and speckle-tracking.
    Bansal M; Jeffriess L; Leano R; Mundy J; Marwick TH
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):121-31. PubMed ID: 20159637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial viability assessment and utility in contemporary management of ischemic cardiomyopathy.
    Katikireddy CK; Samim A
    Clin Cardiol; 2022 Feb; 45(2):152-161. PubMed ID: 35077580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of myocardial viability in ischemic cardiomyopathy.
    Bax JJ
    Heart Lung Circ; 2005; 14 Suppl 2():S8-13. PubMed ID: 16352289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial viability-State of the art: Is it still relevant and how to best assess it with imaging?
    Patel H; Mazur W; Williams KA; Kalra DK
    Trends Cardiovasc Med; 2018 Jan; 28(1):24-37. PubMed ID: 28735783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy.
    Bose A; Kandala J; Upadhyay GA; Riedl L; Ahmado I; Padmanabhan R; Gewirtz H; Mulligan LJ; Singh JP
    J Cardiovasc Electrophysiol; 2014 May; 25(5):507-513. PubMed ID: 24350650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dobutamine echocardiography, dobutamine sestamibi, and rest-redistribution thallium-201 single-photon emission computed tomography for determining contractile reserve and myocardial ischemia in ischemic cardiomyopathy.
    Amanullah AM; Chaudhry FA; Heo J; Galatro K; Dourdoufis P; Brozena S; Narula J; Iskandrian AE
    Am J Cardiol; 1999 Sep; 84(6):626-31. PubMed ID: 10498129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reverse-remodeling after coronary artery bypass grafting in ischemic cardiomyopathy: assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons.
    Ogawa M; Doi K; Fukumoto A; Yaku H
    Interact Cardiovasc Thorac Surg; 2007 Oct; 6(5):673-5. PubMed ID: 17670732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and outcomes of patients with severe left ventricular dysfunction undergoing cardiac MRI viability assessment prior to revascularization.
    Doukas D; Porcaro K; Marot J; Burke L; Joyce C; Weaver F; Nguyen J; Cao JJ; Mathew V; Heroux A; Syed MA
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):675-684. PubMed ID: 33034865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI assessment of myocardial viability: comparison with other imaging techniques.
    Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
    Rays; 1999; 24(1):96-108. PubMed ID: 10358387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.